Trial NCT03742349

View at ClinicalTrials.gov 
Org. Study IDs: CADPT01A12101C
Secondary IDs: 2018-002244-82

Last trial update was posted on 2024-01-19

MeSH Interventions

Spartalizumab

MeSH Conditions

Breast Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Triple Negative Breast Cancer (TNBC)

Stopping Reasons

This was a sponsor decision and was not a consequence of any safety concern

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID